Article ; Online: American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 2.
Arthritis & rheumatology (Hoboken, N.J.)
2021 Volume 73, Issue 8, Page(s) e30–e45
Abstract: ... COVID-19) vaccines for patients with rheumatic and musculoskeletal diseases (RMDs).: Methods ... agreed upon with consensus to provide guidance for use of the COVID-19 vaccines in RMD patients and ... and to facilitate implementation of vaccination strategies for RMD patients. ...
| Abstract | Objective: To provide guidance to rheumatology providers on the use of coronavirus disease 2019 (COVID-19) vaccines for patients with rheumatic and musculoskeletal diseases (RMDs). Methods: A task force was assembled that included 9 rheumatologists/immunologists, 2 infectious disease specialists, and 2 public health physicians. After agreeing on scoping questions, an evidence report was created that summarized the published literature and publicly available data regarding COVID-19 vaccine efficacy and safety, as well as literature for other vaccines in RMD patients. Task force members rated their agreement with draft consensus statements on a 9-point numerical scoring system, using a modified Delphi process and the RAND/University of California Los Angeles Appropriateness Method, with refinement and iteration over 2 sessions. Consensus was determined based on the distribution of ratings. Results: Despite a paucity of direct evidence, 74 draft guidance statements were developed by the task force and agreed upon with consensus to provide guidance for use of the COVID-19 vaccines in RMD patients and to offer recommendations regarding the use and timing of immunomodulatory therapies around the time of vaccination. Conclusion: These guidance statements, made in the context of limited clinical data, are intended to provide direction to rheumatology health care providers on how to best use COVID-19 vaccines and to facilitate implementation of vaccination strategies for RMD patients. |
|---|---|
| MeSH term(s) | Academies and Institutes ; Advisory Committees ; COVID-19/prevention & control ; COVID-19 Vaccines/standards ; Consensus ; Delphi Technique ; Humans ; Immunologic Factors/therapeutic use ; Musculoskeletal Diseases/drug therapy ; Musculoskeletal Diseases/immunology ; Practice Guidelines as Topic/standards ; Rheumatic Diseases/drug therapy ; Rheumatic Diseases/immunology ; Rheumatology/standards ; SARS-CoV-2 ; United States |
| Chemical Substances | COVID-19 Vaccines ; Immunologic Factors |
| Language | English |
| Publishing date | 2021-06-15 |
| Publishing country | United States |
| Document type | Journal Article |
| ZDB-ID | 2756371-6 |
| ISSN | 2326-5205 ; 2326-5191 |
| ISSN (online) | 2326-5205 |
| ISSN | 2326-5191 |
| DOI | 10.1002/art.41877 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.A 24: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.